Pathogenic Mechanisms Underlying Stargardt Macular Degeneration Linked to Mutations in the Transmembrane Domains of ABCA4
Abstract
ABCA4 is an ATP-binding cassette (ABC) transporter predominantly expressed in photoreceptors where it transports the substrate N-retinylidene-phosphatidylethanolamine across disc membranes thereby facilitating the clearance of retinal compounds from photoreceptor outer segments. Loss of function mutations in ABCA4 cause the accumulation of bisretinoids leading to Stargardt disease (STGD1) and other retinopathies. In this study, we examined the expression and functional properties of ABCA4 harboring disease-causing missense mutations in the two transmembrane domains (TMDs) of ABCA4. Our results indicate that these mutations lead to protein misfolding, loss in substrate binding, decreased ATPase activity or a combination of these properties. Additionally, we identified an arginine (R653) in transmembrane segment 2 of ABCA4 as a residue essential for substrate binding and substrate-stimulated ATPase activity. The expression and functional activity of the TMD variants correlate well with the severity of STGD1. Our studies provide a basis for developing and evaluating novel treatments for STGD1.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Design, Expression, and Purification of a Soluble Form of the Retina-Specific Membrane Transporter, ABCA4
Albtool A. Alturkestani, Jazzlyn S Jones, … Subhasis B. Biswas·bioRxiv·May 22, 2025
- Rescue of the Stargardt Disease phenotype in Abca4 knockout mice through dietary modulation of the vitamin A receptor RBPR2
Rakesh Radhakrishnan, Matthias Leung, … Glenn Prazere Lobo·FASEB BioAdvancesPeer-reviewed·Aug 1, 2025
- Pathogenic impact of ABCA4 missense variants in the structurally uncharacterized ECD1 region: implications for Stargardt disease.
Nadee N. J. Matarage Don, Subhasis B. Biswas, Esther E. Biswas·bioRxiv·Jul 1, 2026
- Abca4 inhibition in a cone-rich rodent leads to Stargardt Disease type 1-like retinal degeneration
F. Sassone, D. Ciocca, … D. Hicks·bioRxiv·Sep 4, 2023
- An ABCA4 loss-of-function mutation causes a canine form of Stargardt disease
Suvi Mäkeläinen, Marta Gòdia, … Tomas F. Bergström·PLoS GeneticsPeer-reviewed·Mar 19, 2019
- Loss of ABCA4 from photoreceptor discs triggers changes in glial cell homeostasis
Rossella Valenzano, Andrew J. McDonald, … Jan Wijnholds·Stem CellsPeer-reviewed·Aug 10, 2026